Skip to main content

Diphenidine Facts

Dissociative; Diarylethylamine; NMDA receptor antagonist

Description

Diphenidine is a synthetic dissociative of the diarylethylamine class. It blocks glutamate signaling in the brain,[1] cutting off normal nerve communication and producing a state of deep disconnection.

Subjective effects include deep disconnection from surroundings, hallucinations, depersonalization, euphoria, and profound memory loss. The experience is heavier and more enveloping than ketamine — a dense dissociative fog in which memories of what happened frequently fail to form.[2]

Diphenidine triggers dopamine release in the brain's reward circuits,[3] signaling abuse liability; no human dependence cases have been published.[4] The dominant acute risks are cardiovascular stress and severe agitation; 48 deaths are on record worldwide, most involving multiple substances.[4]

Dose and durationby route · individual sensitivity varies

Oral(mg)
Threshold< 15 mgLight40 – 75 mgCommon75 – 120 mgStrong120 – 175 mgHeavy175+ mg

Starts in 15 – 30 minLasts 2 – 5 hoursAfter-effects 4 – 24 hours

Body and dependence

Acute toxicity
Moderate
Chronic toxicity
Moderate
Physical dependence
Low
Psychological dependence
Low
Withdrawal
Mild
Compulsive redosing
Moderate

Tolerance

Builds
Moderate
Fully resets after
10 days
Carries over to
ketamine; phencyclidine; methoxetamine; methoxphenidine; dextromethorphan

Effectslikely at a common dose

Perception
Spatial disorientation; +21 possible, including Double vision, Visual acuity suppression, Vestibular distortion
Body
Motor control impairment; +23 possible, including Dizziness, Nystagmus (eye wobbles), Nausea
Thinking
Cognitive impairment; +21 possible, including Memory suppression, Analysis suppression, Confusion
Feeling
none likely · 5 possible, including Anxiety, Emotional lability
Self
Derealization; +8 possible, including Depersonalization, Communication suppression, Social disconnection
Time
Time alteration; +2 possible, including Temporal disorientation

Who shouldn't take it

Absolute
Psychotic disorders; Pregnancy and breastfeeding
Relative
Hypertension; Cardiac arrhythmia; Bipolar disorder; Hepatic impairment; Renal impairment

Combinations61 recorded

Lethal (2)
GHB, GBL; Ibogaine
Dangerous (36)
Amphetamines; Benzodiazepines; Buprenorphine, Kratom; Ephedrine, Pseudoephedrine; MDMA, Amphetamines; Naltrexone; NDRIs (Wellbutrin); NRIs; NSAIDs; Opioids; THC; Anticholinergics; Antihistamines; Atypical antipsychotics; Benzodiazepines, Barbiturates; Buspirone; Caffeine; Clonidine, Guanfacine; Dopamine agonists; DXM; Gabapentin, Pregabalin; GHB, Baclofen; Ketamine, DXM, PCP; Lithium; and 12 more, see full page
Caution (20)
See full page: psychedex.org/substances/diphenidine
Not graded (3)
Not listed never means safe.

Seek help immediately if

  • Severe disorientation; unable to move or speak (deep dissociation / "k-hole")
  • Complete loss of coordination — cannot stand or walk safely
  • Vomiting while incapacitated (choking / aspiration risk)
  • Very high blood pressure; fast heart rate
  • Slow or shallow breathing at high doses (especially mixed with depressants)
  • Unconsciousness; rarely, seizures

What to do

  1. Move them somewhere safe, away from stairs, water, roads, and sharp edges — they cannot protect themselves
  2. Place in the recovery position if vomiting or unconscious (aspiration is a key risk)
  3. Stay with them and reassure calmly; keep the environment quiet
  4. If breathing is slow/shallow or they are unresponsive, call emergency services
  5. Do not let them wander; do not leave them alone
  6. Be ready to give rescue breaths / CPR

Effects wear off with time in a safe, monitored setting. The main dangers are physical injury and aspiration while incapacitated, and respiratory depression when combined with other depressants — not the dissociation itself.

988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE

Version r1 · Not medical advice

References

  1. [1]
    ^Wallach J, Kang H, Colestock T, Morris H, Bortolotto ZA, Collingridge GL, Lodge D, Halberstadt AL, Brandt SD, Adejare A (2016) Pharmacological Investigations of the Dissociative 'Legal Highs' Diphenidine, Methoxphenidine and Analogues — PLoS ONE doi:10.1371/journal.pone.0157021
  2. [2]
    ^Gerace E, Bovetto E, Corcia DD, Vincenti M, Salomone A (2017) A Case of Nonfatal Intoxication Associated with the Recreational use of Diphenidine — Journal of Forensic Sciences doi:10.1111/1556-4029.13355
  3. [3]
    ^Sahai MA, Davidson C, Dutta N, Opacka-Juffry J (2018) Mechanistic Insights into the Stimulant Properties of Novel Psychoactive Substances (NPS) and Their Discrimination by the Dopamine Transporter-In Silico and In Vitro Exploration of Dissociative Diarylethylamines — Brain Sciences doi:10.3390/brainsci8040063
  4. [4]
    ^abAdvisory Council on the Misuse of Drugs (ACMD) (2023) ACMD Review of the Evidence on the Use and Harms of Diphenidine (including methoxphenidine) Link
Print version
Report an issue